Previous 10 | Next 10 |
home / stock / ilmn / ilmn articles
Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 12.7% on an annualized basis producing an average annual return of 21....
Wednesday, Illumina Inc (NASDAQ:ILMN) acquired Fluent BioSciences to expand its reach in single-cell analysis and multiomics research for...
Last month, Illumina Inc (NASDAQ:ILMN) had to let go of Grail Inc. Still, the DNA sequencing company has acquired Fluent BioSciences to expand its ...
Following three years of nonstop regulatory hassles, Illumina (NASDAQ: ILMN) finally gave up on GRAIL (NASDAQ: GRAL), leading to the successful com...
Nearly four years after first pitching for Grail Inc. (NASDAQ:GRAL), Illumina Inc. (NASDAQ:ILMN) announced Monday that it would spin off the cancer...
On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management expects Amazon.com, Inc. (NASDAQ:AMZN) to go ...
These large-cap stocks were the best performers in the last week. Are they in your portfolio? Guidewire Software, Inc. (NYSE:GWRE) shares surged 1...
S&P Dow Jones Indices announced late Friday changes to various S&P indices, coinciding with the quarterly rebalance. Notable among the addi...
U.S. stocks were slightly higher, with the Dow Jones index gaining around 0.1% on Thursday. Shares of The J. M. Smucker Company (NYSE:SJM) rose sha...
News, Short Squeeze, Breakout and More Instantly...
Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 PR Newswire SAN DIEGO , July 11, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ:ILMN) previously announced on June 24 , the company will issue results for the second qu...
The Illumina iHope China program will provide 1800 families with genetic testing in 2024, broadening its reach and impact nationwide Originally published on Illumina News Center NORTHAMPTON, MA / ACCESSWIRE / July 11, 2024 / This year may be the most impactful yet in the short history o...
Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base PR Newswire Accessible, highly scalable single-cell technology expands Illumina's multiomics capabilities SAN DIEGO , July 9, 2024 /PRNews...